Volker Fischer - Drug Metab Pharmacokinet & Bioanal, AbbVie Inc

基本信息

浏览量：5

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 15 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Mathematical and Experimental Validation of Flux Dialysis Method: an Improved Approach to Measure Unbound Fraction for Compounds with High Protein Binding and Other Challenging Properties

J. Cory Kalvass,Colin Phipps,Gary J. Jenkins,Patricia Stuart,Xiaomei Zhang,Lance Heinle,Marjoleen J. M. A. Nijsen,Volker Fischer

Drug metabolism and disposition the biological fate of chemicals（2018）

引用41浏览0WOS引用

Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug-Drug Interaction Between Clopidogrel and Dasabuvir

M. Shebley, W. Fu,P. Badri, D. A. J. Bow,V. Fischer

Clinical Pharmacology & Therapeuticsno. 4 (2017): 679-687

引用28浏览0WOS引用

In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context

H. Lennernas,A. Lindahl,A. Van Peer,C. Ollier,T. Flanagan,R. Lionberger,A. Nordmark,S. Yamashita,L. Yu,G. L. Amidon,V. Fischer,E. Sjogren,P. Zane,M. McAllister,B. Abrahamsson

Molecular Pharmaceutics（2017）

引用51浏览0WOS引用

Mechanisms and Predictions of Drug-Drug Interactions of the Hepatitis C Virus Three Direct-Acting Antiviral Regimen: Paritaprevir/Ritonavir, Ombitasvir, and Dasabuvir

Mohamad Shebley,Jinrong Liu,Olga Kavetskaia,Jens Sydor,Sonia M. de Morais,Volker Fischer,Marjoleen J. M. A. Nijsen,Daniel A. J. Bow

Drug metabolism and disposition the biological fate of chemicals（2017）

引用38浏览0WOS引用

Metabolism and Disposition of Hepatitis C Polymerase Inhibitor Dasabuvir in Humans

Jianwei Shen,Michael Serby,Aimee Reed,Anthony J. Lee,Rajeev Menon,Xiaomei Zhang,Kennan Marsh,Xia Wan,Olga Kavetskaia,Volker Fischer

Drug Metabolism and Disposition（2016）

引用13浏览0WOS引用

Metabolism and Disposition of the Hepatitis C Protease Inhibitor Paritaprevir in Humans

Jianwei Shen,Michael Serby,Aimee Reed,Anthony J. Lee,Xiaomei Zhang,Kennan Marsh,Amit Khatri,Rajeev Menon,Olga Kavetskaia,Volker Fischer

Drug Metabolism and Disposition（2016）

引用18浏览0WOS引用

Metabolism and Disposition of Pan-Genotypic Inhibitor of Hepatitis C Virus NS5A Ombitasvir in Humans

Jianwei Shen,Michael Serby,Bruce Surber,Anthony J. Lee,Junli Ma,Prajakta Badri,Rajeev Menon,Olga Kavetskaia,Sonia M. de Morais,Jens Sydor,Volker Fischer

Drug Metabolism and Disposition（2016）

引用13浏览0WOS引用

ASSESSMENT OF DRUG-DRUG INTERACTION POTENTIAL BETWEEN DASABUVIR AND CLOPIDOGREL USING PBPK MODELING AND SIMULATIONS: A CASE OF SUCCESSFUL REGULATORY SUBMISSION USING PBPK

M. Shebley, W. Fu,Y. Pang,D. Bow,V. Fischer

CLINICAL PHARMACOLOGY & THERAPEUTICSno. SUPnan (2016): S66-S66

引用0浏览0引用

Evaluation of Various Static in Vitro–In Vivo Extrapolation Models for Risk Assessment of the CYP3A Inhibition Potential of an Investigational Drug

CLINICAL PHARMACOLOGY & THERAPEUTICSno. 2 (2014): 189-198

引用87浏览0WOS引用

DRUG-DRUG INTERACTION SIMULATIONS OF TIME-DEPENDENT CYP2C19 INHIBITION ON OMEPRAZOLE AND PROGESTERONE FROM IN VITRO METABOLISM DATA USING SIMCYP SIMULATOR

Jinrong Liu,Ning Liu,Robert A. Carr,Kennan C. Marsh,Sonia de Morais,Volker Fischer

DRUG METABOLISM REVIEWS（2014）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn